Relief by botulinum toxin of voiding dysfunction due to prostatitis.
Maria
G
G
Destito
A
A
Lacquaniti
S
S
Bentivoglio
A R
AR
Brisinda
G
G
Albanese
A
A
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D011472:Prostatitis / Q000150:complications*; D013997:Time Factors; D016896:Treatment Outcome; D014524:Urethral Obstruction / Q000188:drug therapy* / Q000209:etiology*
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A